Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1 in vitro

References

• An X, Wu WR, Lai HL, Yang L, Tan XN, Huang ZB. 2019. Research progress in molecular pharmacognosy of Pogostemon cablin. Zhongguo Zhong Yao Za Zhi. 44:4781–4785.
   PubMedGoogle Scholar
• Cao ZX, Yang YT, Yu S, Li YZ, Wang WW, Huang J, Xie XF, Xiong L, Lei S, Peng C. 2017. Pogostone induces autophagy and apoptosis involving PI3K/Akt/mTOR axis in human colorectal carcinoma HCT116 cells. J Ethnopharmacol. 202:20–27.
   PubMed Web of Science ®Google Scholar
• Chen H, Li Y, Wu X, Li C, Li Q, Qin Z, Yi Y, Chen J, Lai X, Su Z. 2013. LC-MS/MS determination of pogostone in rat plasma and its application in pharmacokinetic studies. Biomed Chromatogr. 27(9):1092–1099.
   PubMed Web of Science ®Google Scholar
• Chen H, Liao H, Liu Y, Zheng Y, Wu X, Su Z, Zhang X, Lai Z, Lai X, Lin ZX, et al. 2015. Protective effects of pogostone from Pogostemonis Herba against ethanol-induced gastric ulcer in rats. Fitoterapia. 100:110–117.
   PubMed Web of Science ®Google Scholar
• Chen XY, Chen HM, Liu YH, Zhang ZB, Zheng YF, Su ZQ, Zhang X, Xie JH, Liang YZ, Fu LD, et al. 2016. The gastroprotective effect of pogostone from Pogostemonis Herba against indomethacin-induced gastric ulcer in rats. Exp Biol Med. 241(2):193–204.
   Web of Science ®Google Scholar
• Curran MP. 2010. Amlodipine/atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease. Drugs. 70(2):191–213.
   PubMed Web of Science ®Google Scholar
• Gentz BA, Malan TP. Jr. 2001. Renal toxicity with sevoflurane: a storm in a teacup? Drugs. 61(15):2155–2162.
   PubMed Web of Science ®Google Scholar
• Guo L, Cui Y, Hao K. 2018. Effects of glycyrrhizin on the pharmacokinetics of asiatic acid in rats and its potential mechanism. Pharm Biol. 56(1):119–123.
   PubMed Web of Science ®Google Scholar
• Hendrikx JJ, Lagas JS, Rosing H, Schellens JH, Beijnen JH, Schinkel AH. 2013. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel. Int J Cancer. 132(10):2439–2447.
   PubMed Web of Science ®Google Scholar
• Henningsson A, Marsh S, Loos WJ, Karlsson MO, Garsa A, Mross K, Mielke S, Viganò L, Locatelli A, Verweij J, et al. 2005. Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel. Clin Cancer Res. 11(22):8097–8104.
   PubMed Web of Science ®Google Scholar
• Kamel EM, Lamsabhi AM. 2020. The quasi-irreversible inactivation of cytochrome P450 enzymes by paroxetine: a computational approach. Org Biomol Chem. 18(17):3334–3345.
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Xie L, Gan D, Jiang X. 2016. Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol. 54(12):2886–2894.
   PubMed Web of Science ®Google Scholar
• Li YC, Xian YF, Su ZR, Ip SP, Xie JH, Liao JB, Wu DW, Li CW, Chen JN, Lin ZX, et al. 2014. Pogostone suppresses proinflammatory mediator production and protects against endotoxic shock in mice. J Ethnopharmacol. 157:212–221.
   PubMed Web of Science ®Google Scholar
• Liu L, Sun S, Rui H, Li XJPB. 2017. In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes. Pharm Biol. 55(1):1868–1874.
   PubMed Web of Science ®Google Scholar
• Osawa K, Matsumoto T, Maruyama T, Takiguchi T, Okuda K, Takazoe I. 1990. Studies of the antibacterial activity of plant extracts and their constituents against periodontopathic bacteria. Bull Tokyo Dent Coll. 31(1):17–21.
   PubMedGoogle Scholar
• Peng F, Wan F, Xiong L, Peng C, Dai M, Chen J. 2014. In vitro and in vivo antibacterial activity of Pogostone. Chin Med J. 127:4001–4005.
   PubMed Web of Science ®Google Scholar
• Schindler E, Hempelmann G. 1998. Perfusion and metabolism of liver and splanchnic nerve area under sevoflurane anesthesia. Anaesthesist. 47 (Suppl 1):S19–S23.
   PubMedGoogle Scholar
• Su JY, Luo X, Zhang XJ, Deng XL, Su ZR, Zhou L, Li SS, Dai Z, Xu Y, Lai XP. 2015. Immunosuppressive activity of pogostone on T cells: blocking proliferation via S phase arrest. Int Immunopharmacol. 26(2):328–337.
   PubMed Web of Science ®Google Scholar
• Sun CY, Xu LQ, Zhang ZB, Chen CH, Huang YZ, Su ZQ, Guo HZ, Chen XY, Zhang X, Liu YH, et al. 2016. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-kappaB signaling pathways. Int Immunopharmacol. 32:55–61.
   PubMed Web of Science ®Google Scholar
• Swamy MK, Sinniah UR. 2015. A comprehensive review on the phytochemical constituents and pharmacological activities of Pogostemon cablin Benth.: an aromatic medicinal plant of industrial importance. Molecules. 20(5):8521–8547.
   PubMed Web of Science ®Google Scholar
• Topletz AR, Dennison JB, Barbuch RJ, Hadden CE, Hall SD, Renbarger JL. 2013. The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine. Drug Metab Dispos. 41(9):1651–1661.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 22(1):1–21.
   PubMed Web of Science ®Google Scholar
• Xiang Q, Li C, Zhao X, Cui YM. 2017. The influence of CYP3A5*3 and BCRPC421A genetic polymorphisms on the pharmacokinetics of felodipine in healthy Chinese volunteers. J Clin Pharm Ther. 42(3):345–349.
   PubMed Web of Science ®Google Scholar
• Yang HM, Zhuo JY, Sun CY, Nie J, Yuan J, Liu YL, Lin RF, Lai XP, Su ZR, Li YC. 2018. Pogostone attenuates TNF-alpha-induced injury in A549 cells via inhibiting NF-kappaB and activating Nrf2 pathways. Int Immunopharmacol. 62:15–22.
   PubMed Web of Science ®Google Scholar
• Yang J, Li Y, Li Y, Rui X, Du M, Wang Z. 2020. Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism. Xenobiotica. 50(6):685–688.
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, et al. 2007. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci. 10(4):496–503.
   PubMed Web of Science ®Google Scholar
• Zhang X, Feng P, Gao X, Wang B, Gou C, Bian RJPB. 2020. In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes. Pharm Biol. 58(1):247–252.
   PubMed Web of Science ®Google Scholar